Dr. Myra Ann Sendelweck, MD

Dr. Sendelweck practices at AdventHealth Castle Rock in Castle Rock, Colorado, part of AdventHealth.

Dr. Sendelweck's NPI, 1841795812, was assigned on March 29, 2018. Dr. Sendelweck holds Colorado license DR.0066750.

Dr. Sendelweck's primary practice is AdventHealth Castle Rock, at 2350 Meadows Blvd, Castle Rock, CO 80109 in Douglas County. The practice phone is (720) 455-5000.

Dr. Sendelweck's primary practice is AdventHealth Castle Rock in Castle Rock, Colorado, part of AdventHealth. Dr. Sendelweck is also affiliated with AdventHealth Parker. The medical group on file is AdventHealth Transplant Institute North Billings.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sendelweck practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Sendelweck's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Sendelweck is licensed in Colorado.

CMS data shows 678 Medicare services from Dr. Sendelweck across 6 procedure codes in 2024, for 267 Medicare patients. Medicare paid $65,935 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 267 Medicare patients who saw Dr. Sendelweck in 2024. The largest group is 75 to 84, with 107 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sendelweck's median patient age at 74, with 54% women.

In 2024, Dr. Sendelweck wrote 223 Medicare Part D claims for 120 patients. 90% of them were for generic drugs. CMS names the drug for 37 of them, across 2 drugs with 11 or more claims each, at $333 in total drug cost. In 2023, CMS named 124 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Sendelweck for performance year 2024, reported as part of a group. Dr. Sendelweck accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Sendelweck, published from 2017 to 2018. The most frequent topics are Health Risk Behaviors, Health Surveys and Hyperpigmentation. Dr. Sendelweck has published most often in Int J Dermatol. Dr. Sendelweck's most frequent co-authors are Kurt Ashack, MD, Ramin Fathi, MD and Stephanie Anne Chapman, MD.

CMS Open Payments shows 2 general payments to Dr. Sendelweck from 2 drug and device companies in 2021. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $22.